Loading clinical trials...
Loading clinical trials...
The Investigators aim to identify speech and language markers that provide information on cognitive function and predict cognitive decline in Parkinson's disease. The Investigators will administer speech tasks and cognitive assessments to participants with Parkinson's disease and healthy controls. The Investigators will also explore the associations between genetic factors and speech and cognitive status in Parkinson's disease.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
UMass Medical School/UMass Memorial Medical Center
Worcester, Massachusetts, United States
Start Date
January 13, 2020
Primary Completion Date
September 1, 2023
Completion Date
February 28, 2025
Last Updated
June 10, 2025
58
ACTUAL participants
Cognitive Battery
DIAGNOSTIC_TEST
Voice, Speech and Language Analysis
BEHAVIORAL
Questionnaires and Clinical Assessments
BEHAVIORAL
DNA Analysis
GENETIC
Lead Sponsor
University of Massachusetts, Worcester
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06113640